LEON sets up lab facilities at the Innovation and Start-Up Center for Biotechnology (IZB) in Munich
leon-nanodrugs GmbH, announced today the establishment of their own lab facilities at the Start-Up Center for Biotechnology (IZB) in Munich.
The new R&D capacities set the stage for completion of product development for LEON’s manufacturing devices and will afterwards be used to showcase the devices and provide process development services to clients using LEON’s equipment.
About LEON
leon-nanodrugs GmbH is a Munich-based pharmatech company specializing in the development of devices for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles (LNPs). LEON builds its innovative solutions based on its proprietary FR-JET® Technology. Its portfolio of devices, NANOscreen® for simplified formulation screening, NANOlab® for process development, and NANOme® and NANOus® for GMP aseptic manufacturing, enable faster route to clinical batches and are suitable for both individualised scales and commercial production.
LEON’s platform is aimed at enabling pharma companies, small biotech, research institutes, as well as CDMOs, to take full advantage of the significant progress being made in advanced therapies.
For general information and enquiries please email info@leon-nanodrugs.com